
Chymase inhibitor TY-51469 in therapy of inflammatory bowel disease
Author(s) -
Weixin Liu,
Ying Wang,
Li-Xuan Sang,
Shen Zhang,
Ting Wang,
Feng Zhou,
Shouzhi Gu
Publication year - 2016
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v22.i5.1826
Subject(s) - intraperitoneal injection , gastroenterology , medicine , inflammatory bowel disease , colitis , saline , chymase , immunohistochemistry , immunology , ulinastatin , group a , inflammation , pathology , endocrinology , mast cell , disease
To investigate the effect of chymase inhibitor TY-51469 in the therapy of inflammatory bowel disease and the underlying mechanism.